文献速递重症综合管理与镇静镇痛

ICU 身体康复研究的对照组:125 项研究的范围综述

Comparator Groups in ICU-Based Studies of Physical Rehabilitation: A Scoping Review of 125 Studies.
PubMed 文献 · Crit Care Explor · 2023-05-09
一句话结论ICU 身体康复研究中对照组以常规照护为主(63.8%),但计划活动异质、CERT 报告中位仅 46.6%,20.0% 研究未报告可理解对照组活动的细节。

本范围综述按五阶段方法检索 5 个数据库(建库至 2022 年 6 月 30 日),纳入在 ICU 启动计划性身体康复、≥2 组、机械通气成人(≥18 岁)的前瞻性研究,最终纳入 125 项研究、127 个对照组。对照组类型以常规照护最常见(81 个,63.8%),其余为替代治疗(18 个,14.2%)、替代治疗加常规照护(7 个,5.5%)和假干预(6 个,4.7%)。112 个计划身体康复的对照组中,90 个(88 项研究)报告了 60 种独特活动,最常见为被动关节活动(47 个,52.2%);22 个(19.6%)描述模糊。CERT 报告项中位仅 46.6%(25.0–73.3%),20.0% 研究未提供可理解对照组计划活动的细节。作者认为结果可指导未来 ICU 身体康复研究对照组的选取、设计与报告。

要点

  • 125 项研究共 127 个对照组,常规照护为最常见类型(81 个,63.8%),替代治疗 18 个(14.2%)、替代治疗加常规照护 7 个(5.5%)、假干预 6 个(4.7%)。
  • 112 个计划身体康复的对照组中,90 个(88 项研究)报告 60 种独特活动,最常见为被动关节活动(47 个,52.2%)。
  • 22 个(19.6%)计划身体康复的对照组仅给出模糊描述,12 个(9.5%)未计划身体康复,3 个(2.4%)无细节。
  • CERT 报告项中位 46.6%(Q1–Q3 25.0–73.3%),20.0% 的研究未报告可理解对照组计划活动的细节。
  • 作者认为结果可指导未来 ICU 身体康复研究对照组的选取、设计与报告。

适用人群与场景

  • 纳入标准:前瞻性研究,≥2 个研究组,机械通气成人(≥18 岁),在 ICU 启动任何计划性身体康复干预。
  • 检索数据库 5 个,检索时间自建库至 2022 年 6 月 30 日;研究筛选与数据提取由两人独立、重复完成。

诊断标准与关键阈值

  • 对照组报告评估采用 Consensus on Exercise Reporting Template(CERT),以报告项数/适用总项数的比例表示。

研究设计与关键结果

  • 研究类型:范围综述(scoping review),按五阶段方法学,纳入 125 项研究、127 个对照组。
  • 对照组类型:常规照护 81 个(63.8%)、替代治疗(如与干预不同)18 个(14.2%)、替代治疗加常规照护 7 个(5.5%)、假干预 6 个(4.7%)。
  • 112 个计划身体康复的对照组中,90 个(88 项研究)报告 60 种独特活动,最常见为被动关节活动(47 个,52.2%)。
  • 22 个(19.6%;22 项研究)计划身体康复的对照组描述模糊;12 个(9.5%;12 项研究)未计划身体康复;3 个(2.4%;3 项研究)无细节。
  • CERT 报告项中位 46.6%(Q1–Q3 25.0–73.3%);20.0% 的研究未报告可理解对照组计划活动的细节。

证据类型、等级与局限

  • 证据类型:范围综述,按五阶段范围综述方法学,检索 5 个数据库,研究筛选与数据提取由两人独立、重复完成。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,其结果可帮助指导未来 ICU 身体康复研究中对照组的选取、设计与报告。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: To characterize comparator groups (CGs) in ICU-based studies of physical rehabilitation (PR), including the type, content, and reporting.

DATA SOURCES: We followed a five-stage scoping review methodology, searching five databases from inception to June 30, 2022. Study selection and data extraction were completed independently, in duplicate.

STUDY SELECTION: We screened studies by title and abstract, then full-text. We included prospective studies with greater than or equal to two arms enrolling mechanically ventilated adults (≥ 18 yr), with any planned PR intervention initiated in the ICU.

DATA EXTRACTION: We conducted a quantitative content analysis of authors' description of CG type and content. We categorized similar CG types (e.g., usual care), classified content into unique activities (e.g., positioning), and summarized these data using counts (proportions). We assessed reporting using Consensus on Exercise Reporting Template (CERT; proportion of reported items/total applicable).

DATA SYNTHESIS: One hundred twenty-five studies were included, representing 127 CGs. PR was planned in 112 CGs (88.2%; 110 studies), representing four types: usual care (n = 81, 63.8%), alternative treatment than usual care (e.g., different from intervention; n = 18, 14.2%), alternative treatment plus usual care (n = 7, 5.5%), and sham (n = 6, 4.7%). Of 112 CGs with planned PR, 90 CGs (88 studies) reported 60 unique activities, most commonly passive range of motion (n = 47, 52.2%). The remaining 22 CGs (19.6%; 22 studies) reported vague descriptions. PR was not planned in 12 CGs (9.5%; 12 studies), and three CGs (2.4%; three studies) reported no details. Studies reported a median (Q1-Q3) of 46.6% (25.0-73.3%) CERT items. Overall, 20.0% of studies reported no detail to understand planned CG activities.

CONCLUSIONS: The most common type of CG was usual care. We identified heterogeneity in planned activities and CERT reporting deficiencies. Our results could help guide the selection, design, and reporting of CGs in future ICU-based PR studies.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. O'Grady HK, Reid JC, Farley C, et al. Comparator Groups in ICU-Based Studies of Physical Rehabilitation: A Scoping Review of 125 Studies. Crit Care Explor. 2023. PMID: 37181539. doi:10.1097/CCE.0000000000000917

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。